Ground News

News from Tarrytown

Stay current with all the latest and breaking news about Tarrytown, compare headlines and perspectives between news sources on stories happening today. In total, 34 stories have been published about Tarrytown which Ground News has aggregated in the past 3 months.

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Tarrytown News

Finance · Tarrytown

Price Over Earnings Overview: Regeneron Pharmaceuticals - Regeneron Pharmaceuticals (NASDAQ:REGN)

100% Center coverage: 1 sources

See the Story

FDA · Tarrytown

EYLEA HD® (aflibercept) Injection 8 mg Positive Phase 3 Results in Patients with Macular Edema following Retinal Vein Occlusion Presented at Angiogenesis Meeting - Regeneron Pharmaceuticals (NASDAQ:REGN)

100% Center coverage: 1 sources

TARRYTOWN, N.Y., Feb. 08, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced the first presentation of positive results from the Phase 3 QUASAR trial investigating EYLEA HD® (aflibercept) Injection 8 mg for the treatment of patients with macular edema following retinal vein occlusion (RVO), including those with central, branch and hemiretinal vein occlusions. The data were presented today at the virtual Angiog…See the Story

Tarrytown · Tarrytown

Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years - Regeneron Pharmaceuticals (NASDAQ:REGN)

100% Center coverage: 1 sources

See the Story

News from Tarrytown

News from Tarrytown

Local News Publishers

Top Tarrytown News

Price Over Earnings Overview: Regeneron Pharmaceuticals - Regeneron Pharmaceuticals (NASDAQ:REGN)

EYLEA HD® (aflibercept) Injection 8 mg Positive Phase 3 Results in Patients with Macular Edema following Retinal Vein Occlusion Presented at Angiogenesis Meeting - Regeneron Pharmaceuticals (NASDAQ:REGN)

Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years - Regeneron Pharmaceuticals (NASDAQ:REGN)

Local News Publishers

Breaking News Topics Related to Tarrytown

Breaking News Topics Related to Tarrytown

Top Tarrytown News

Price Over Earnings Overview: Regeneron Pharmaceuticals - Regeneron Pharmaceuticals (NASDAQ:REGN)

EYLEA HD® (aflibercept) Injection 8 mg Positive Phase 3 Results in Patients with Macular Edema following Retinal Vein Occlusion Presented at Angiogenesis Meeting - Regeneron Pharmaceuticals (NASDAQ:REGN)

Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years - Regeneron Pharmaceuticals (NASDAQ:REGN)

Three-Year Results for EYLEA HD (aflibercept) Injection 8 mg in Patients with Wet Age-related Macular Degeneration Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals

‘Unfit specialists’ doing dental work

Marcus Stroman Away From Yankees Camp As Trade Talks Swirl

LeMahieu Enters Yankees Camp At 100%, Resurgence On Cards

Rays on temp home: Uncertainty 'is what we do'

Rehabilitation Through the Arts Names Program Alum Jermaine Archer as Executive Director - River Journal Online - News for Tarrytown, Sleepy Hollow, Irvington, Ossining, Briarcliff Manor, Croton-on-Hudson, Cortlandt and Peekskill

Westchester's Top Students Scientists Feted at Regeneron Event - River Journal Online - News for Tarrytown, Sleepy Hollow, Irvington, Ossining, Briarcliff Manor, Croton-on-Hudson, Cortlandt and Peekskill

Regeneron’s earnings boosted by demand for blockbuster eye drug Eylea